Loss of hepatic TMEM41B or VMP1 results in severe defects in VLDL secretion and leads to the rapid development of metabolic dysfunction-associated steatohepatitis (MASH) in mice. Here, VMP1 is linked to metabolic dysfunction-associated steatohepatitis.